MENU
+Compare
CHE
Stock ticker: NYSE
AS OF
Sep 17, 04:59 PM (EDT)
Price
$457.60
Change
+$9.97 (+2.23%)
Capitalization
6.52B

CHE Chemed Corp Forecast, Technical & Fundamental Analysis

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value... Show more

CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CHE with price predictions
Sep 16, 2025

CHE sees MACD Histogram just turned negative

CHE saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 12, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 51 instances where the indicator turned negative. In of the 51 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CHE as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CHE moved below its 50-day moving average on September 12, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for CHE crossed bullishly above the 50-day moving average on September 05, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 208 cases where CHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.562) is normal, around the industry mean (6.214). P/E Ratio (23.539) is within average values for comparable stocks, (116.131). Projected Growth (PEG Ratio) (1.820) is also within normal values, averaging (1.971). Dividend Yield (0.005) settles around the average of (0.039) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (1.443).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CHE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CHE is expected to report earnings to rise 26.23% to $5.39 per share on October 29

Chemed Corp CHE Stock Earnings Reports
Q3'25
Est.
$5.39
Q2'25
Missed
by $1.12
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.05
Q3'24
Missed
by $0.12
The last earnings report on July 29 showed earnings per share of $4.27, missing the estimate of $5.39. With 307.92K shares outstanding, the current market capitalization sits at 6.52B.
A.I.Advisor
published Dividends

CHE paid dividends on August 29, 2025

Chemed Corp CHE Stock Dividends
А dividend of $0.60 per share was paid with a record date of August 29, 2025, and an ex-dividend date of August 11, 2025. Read more...
A.I. Advisor
published General Information

General Information

a holding medical company

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
255 East Fifth Street
Phone
+1 513 762-6690
Employees
15087
Web
https://www.chemed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KMKCX73.47N/A
N/A
Kinetics Market Opportunities Adv C
GGCPX16.08N/A
N/A
Goldman Sachs International T/M Eq P
WCFOX13.13N/A
N/A
WCM Focused International Opps Inv
ABLYX28.50-0.02
-0.07%
American Beacon Large Cap Value Y
CMLCX61.31-0.05
-0.08%
American Funds American Mutual 529C

CHE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CHE has been loosely correlated with OPCH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then OPCH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+1.22%
OPCH - CHE
44%
Loosely correlated
-1.18%
UHS - CHE
36%
Loosely correlated
-1.75%
NHC - CHE
33%
Poorly correlated
-0.68%
LTGHF - CHE
32%
Poorly correlated
N/A
HCA - CHE
32%
Poorly correlated
-0.67%
More

Groups containing CHE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+1.22%
Hospital/Nursing Management
industry (89 stocks)
21%
Poorly correlated
+0.09%